Skip to content
Advertisement

FILE - This May 13, 2015, file photo, shows the North American headquarters of Bayer Healthcare in Whippany, N.J. U.S. health officials are placing new restrictions on a contraceptive implant that has been subject to thousands of reports of painful complications from women. But the metal implant, called Essure, will remain on the market. The Food and Drug Administration said Monday, April 9, 2018, that only women who read and sign a brochure about the risks of the device will be able to receive the implant made by manufacturer Bayer. (AP Photo/Julio Cortez, File)

FILE - This May 13, 2015, file photo, shows the North American headquarters of Bayer Healthcare in Whippany, N.J. U.S. health officials are placing new restrictions on a contraceptive implant that has been subject to thousands of reports of painful complications from women. But the metal implant, called Essure, will remain on the market. The Food and Drug Administration said Monday, April 9, 2018, that only women who read and sign a brochure about the risks of the device will be able to receive the implant made by manufacturer Bayer. (AP Photo/Julio Cortez, File)

Featured Photo Galleries